Evidence map›Paper›PMID 28258146›Full record

ArticleApplied and environmental microbiology2017

A Broad-Host-Range Tailocin from Burkholderia cenocepacia.

Guichun W Yao, Iris Duarte, Tram T Le, Lisa Carmody, John J LiPuma, Ry Young, Carlos F Gonzalez

Open access · hybridAbstract read
In one paragraph

Article in Applied and environmental microbiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
5.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 81 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Beyond kin killing:ISME communications · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Does Phage Therapy Need a Pan-Phage?Pathogens (Basel, Switzerland) · 2024
    Review
  17. Article
  18. Phage therapy to treat cystic fibrosisFrontiers in microbiology · 2024
    Review
  19. Pantailocins: phage-derived bacteriocins fromApplied and environmental microbiology · 2023
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Guichun W YaoDepartment of Plant Pathology and Microbiology, Texas A&M University, College Station, Texas, USA.
Iris DuarteDepartment of Plant Pathology and Microbiology, Texas A&M University, College Station, Texas, USA.
Tram T LeDepartment of Plant Pathology and Microbiology, Texas A&M University, College Station, Texas, USA.
Lisa CarmodyDepartment of Pediatrics and Communicable Diseases, University of Michigan Medical School, Ann Arbor, Michigan, USA.
John J LiPumaDepartment of Pediatrics and Communicable Diseases, University of Michigan Medical School, Ann Arbor, Michigan, USA.
Ry YoungCenter for Phage Technology, Texas A&M University, College Station, Texas, USA.
Carlos F GonzalezDepartment of Plant Pathology and Microbiology, Texas A&M University, College Station, Texas, USA cf-gonzalez@tamu.edu.
Texas A&M University · USUniversity of Michigan–Ann Arbor · US

Funding

CONTROL OF VIRUS-INDUCED LYSISR01GM027099 · NIGMS · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI YOUNG, RYLAND FLETCHER · 1985 to 2019
$4.6M
NIGMS NIH HHS R01 GM027099
6 · The paper itself

Abstract

The

Indexed as

Anti-Bacterial AgentsBacteriocinsBurkholderia cenocepaciaBurkholderia cepacia complexGenome, BacterialGenome, ViralHost SpecificityHumansMass SpectrometryMolecular StructurePseudomonas aeruginosaAnti-Bacterial AgentsBacteriocinsbroad host rangeBurkholderia cenocepaciaLPSreceptortailocin

Identifiers

PMID28258146
PMCPMC5411513
OpenAlexW2592660069

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.